xconomy.com -- The mystery surrounding San Diego’s Evoke Pharma is beginning to clear. The specialty drug company co-founded by serial entrepreneur Cam Garner has been operating in stealth mode and has said little about the experimental drug it is developing for gastroparesis, a digestive disorder that affects diabetics. But a recent quarterly filing from a third party, Questcor of Hayward, Calif., contains some new information.
